Among these networks, the PI3K/Akt/mTOR axis appears especially promising for therapeutic intervention, as it integrates signals from multiple HCC pathways that regulate proliferation, survival, and drug resistance. The gene discussed is AKT1; the disease is hepatocellular carcinoma.